is tirzepatide approved for sleep apnea In a prespecified secondary analysis of the SURMOUNT-OSA trial it was found that improves cardiometabolic outcomes in patients with moderate-to-severe OSA and obesity Diabetes & Weight Loss Drug

A new study led byMayo Clinicfound that postmenopausal women receiving menopausal hormone therapy lost 35% more weight while takingtirzepatide, a Food and Drug Administration-approved drug for the treatment of overweight and obesity

Studies show up to 25-39% of weight lost on GLP-1s can come from lean mass - without intentional resistance training and adequate protein

Understanding the role of GLP-1 for weight loss is part of an integrative medicine doctor's fundamental role in treating the whole person.

Understanding tirzepatide injection volumes is essential for safe self-administration

These findings underscore the potential for GLP-1 RAs to offer tailored protection against complex diabetic complications, marking an advancement in personalized medicine for managing diabetes-acute kidney disease.